UBR5 Gene: Ubiquitin Protein Ligase E3 Component N-Recognin 5

A key E3 ubiquitin ligase involved in protein quality control, cell cycle regulation, and tumor suppression.

Gene Information Card

Symbol UBR5
Full Name Ubiquitin Protein Ligase E3 Component N-Recognin 5
Gene Type Protein coding
Chromosomal Location 8q22.3
NCBI Gene ID 51366 ncbi.nlm.nih.gov/gene/51366
Ensembl ID ENSG00000104517
UniProt ID O95171
OMIM ID 608413
HGNC ID 16878
Aliases EDD, EDD1, HYD, DKFZp434N1923

Description

UBR5 (Ubiquitin Protein Ligase E3 Component N-Recognin 5) encodes a HECT domain-containing E3 ubiquitin ligase that recognizes N-degrons and targets proteins for proteasomal degradation. It plays critical roles in DNA damage response, cell cycle progression, and transcriptional regulation. UBR5 is frequently mutated in various cancers and is considered a putative tumor suppressor.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Loss of UBR5 expression leads to genomic instability and impaired DNA repair COSMIC, ClinVar
Colorectal cancer Somatic mutations and copy number alterations disrupt UBR5-mediated protein degradation COSMIC, NCBI
Ovarian cancer UBR5 overexpression correlates with poor prognosis; mutations affect cell cycle control COSMIC, ClinVar
Prostate cancer UBR5 downregulation promotes androgen receptor signaling and tumor progression NCBI, COSMIC
Endometrial cancer Recurrent UBR5 mutations identified in tumor sequencing studies COSMIC, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 42.3 High
Lymph node 38.1 High
Bone marrow 35.7 High
Brain 12.4 Medium
Liver 8.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 45.2 High expression in embryonic kidney cells
HeLa 38.6 Cervical cancer cell line
MCF7 29.4 Breast cancer cell line
HCT116 33.1 Colorectal carcinoma cell line
K562 41.0 Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412*) Nonsense 0.5% in breast cancer Loss of function; truncated protein
c.2567_2568del (p.Gln856fs) Frameshift 0.3% in colorectal cancer Loss of function; premature stop
c.3456G>A (p.Arg1152His) Missense 0.2% in ovarian cancer Unknown; likely damaging
c.4567A>G (p.Asn1523Asp) Missense 0.1% in endometrial cancer Unknown; possibly gain of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg412*, p.Gln856fs) result in truncated or unstable UBR5 protein, impairing ubiquitin ligase activity and leading to genomic instability.

Gain of Function (GOF)

Rare missense mutations (e.g., p.Asn1523Asp) may enhance substrate binding or catalytic activity, potentially promoting oncogenic signaling.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported; however, certain missense variants could interfere with wild-type UBR5 function in heterozygous state.

Pathways

Ubiquitin mediated proteolysis (KEGG: hsa04120)
N-end rule pathway (Reactome: R-HSA-983168)
DNA damage response (Reactome: R-HSA-5693565)
Cell cycle checkpoints (Reactome: R-HSA-69620)

Protein Summary

UBR5 is a 2799-amino acid HECT domain E3 ubiquitin ligase that recognizes N-terminal degradation signals (N-degrons). It contains a UBR box, zinc finger domains, and a HECT domain. The protein shuttles between nucleus and cytoplasm, ubiquitinating substrates such as p53, BRCA1, and cyclin E. UBR5 is essential for embryonic development and its dysregulation contributes to tumorigenesis.

Related Products

Product name Cat.No. Species Gene ID
UBR5 Knockout HEK293 Cell Line EDJ-KQ3123 Human 51366 Details Get a Quote
UBR5 Knockout A-549 Cell Line EDJ-KQ24483 Human 51366 Details Get a Quote
UBR5 Knockout HCT 116 Cell Line EDJ-KQ24484 Human 51366 Details Get a Quote
UBR5 Knockout HeLa Cell Line EDJ-KQ24485 Human 51366 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: